Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
118.60
+5.23 (+4.61%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
What You Missed On Wall Street This Past Friday
Today 6:00 EST
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
Via
Talk Markets
Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
November 01, 2024
Lawyers for the plaintiff had been arguing for a $6.2 billion verdict.
Via
Investor's Business Daily
AbbVie’s Dividend Isn’t As Scary As It Looks
October 30, 2024
AbbVie currently pays shareholders a quarterly dividend of $1.55 per share, which gives the stock a 3.3% yield on the current price.
Via
Talk Markets
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
October 30, 2024
The stocks on this list are the top three buy-and-hold stocks in healthcare, producing significant value for shareholders while leading their respective fields.
Via
MarketBeat
Exposures
COVID-19
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 26, 2024
These healthcare stocks have fantastic dividend track records.
Via
The Motley Fool
P/E Ratio Insights for Abbott Laboratories
October 22, 2024
Via
Benzinga
Is Abbott Laboratories Stock a Buy?
October 17, 2024
The healthcare stock is lagging the market this year.
Via
The Motley Fool
Price Over Earnings Overview: Abbott Laboratories
October 16, 2024
Via
Benzinga
Beat the Nasdaq With This Cash-Gushing Dividend Stock
October 23, 2024
The company is performing well despite recently losing its biggest growth driver.
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
October 19, 2024
These companies' longtime shareholders have generally been rewarded.
Via
The Motley Fool
MarketBeat Week in Review – 10/14 - 10/18
October 19, 2024
Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
October 18, 2024
The Dow Jones and S&P 500 hit highs as they extended weekly win streaks.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Abbott Labs Earnings Edge Past Q3 Views, Led By Medical Devices
October 16, 2024
Medical devices led organic sales growth.
Via
Investor's Business Daily
A Glimpse of Abbott Laboratories's Earnings Potential
October 15, 2024
Via
Benzinga
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
October 18, 2024
These stocks could deliver big over the long term.
Via
The Motley Fool
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
October 17, 2024
Abbott Laboratories reported Q3 sales of $10.64 billion, driven by 8.2% organic growth in medical devices. Adjusted EPS for 2024 projected at $4.64-$4.70, with expectations of double-digit growth...
Via
Benzinga
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
October 17, 2024
Via
Benzinga
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
October 17, 2024
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.
Via
Benzinga
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
October 17, 2024
Via
Benzinga
Why Abbott Laboratories Stock Was a Winner on Wednesday
October 16, 2024
Investors bumped its shares higher following a decent, if unspectacular, earnings report.
Via
The Motley Fool
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
October 16, 2024
ABT earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday?
October 16, 2024
Small-cap stocks outperformed large caps in Wednesday's session, with the Russell 2000 Index surging to test July 2024 highs on the back of expectations for interest rate cuts and a strong rally in...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
Via
Benzinga
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
October 16, 2024
Via
Benzinga
Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
October 16, 2024
Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results align with the trend.
Via
MarketBeat
Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast
October 16, 2024
Abbott Laboratories reported third-quarter 2024 sales of $10.64B, with Medical Devices leading 11.7% sales growth. Adjusted EPS of $1.21 beat analyst expectations. Full-year guidance was updated.
Via
Benzinga
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
October 16, 2024
U.S. stock futures point to a flattish start on Wednesday after the S&P 500 Index and the Dow Jones Industrial Average retreated from record highs in the previous session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
October 16, 2024
Via
Benzinga
Nasdaq Dips 1% Amid Plunge In Chipmaker Stocks: Fear & Greed Index Moves To 'Greed' Zone
October 16, 2024
Via
Benzinga
Morgan Stanley, Abbott Laboratories And 3 Stocks To Watch Heading Into Wednesday
October 16, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.